MORPHOLOGICAL CHANGES OF THE MACULA ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE DIABETIC POPULATION

Main Article Content

Dr. Faiza Mushtaque
Dr. Fizzah Farooq
Dr. Fahad Khan
Dr. Qurat ul Ain Sheikh
Dr. Tahira Sadaf
Dr. Kajal

Keywords

Diabetic Retinopathy, Optical Coherence Tomography Angiography, Foveal Avascular Zone, NPDR, PDR, Microvascular Abnormalities, OCTA

Abstract

Objective: This study aims to investigate morphological alterations in the macula using Optical Coherence Tomography Angiography (OCTA) among diabetic patients, focusing on quantitative changes in the foveal avascular zone (FAZ) and qualitative retinal microvascular features, with the ultimate goal of understanding early diagnostic markers for diabetic retinopathy (DR).


Methods: A descriptive, observational, cross-sectional study was conducted at the Ophthalmology Department of Dr. Ruth K. M. Pfau Civil Hospital, Karachi. A total of 315 diabetic patients, aged 18 years and above, were evaluated using OCTA. The scan parameters were standardized, and the FAZ area, intraretinal microvascular abnormalities (IRMA), microaneurysms, capillary non-perfusion, and neovascularization were documented and analyzed against the duration of diabetes and stage of diabetic retinopathy (NPDR, PDR, ADED).


Results: NPDR was the most prevalent stage of DR (72.7%). The mean FAZ area was significantly larger in patients with PDR and ADED stages, with mean values reaching up to 2.79 mm² in the most advanced disease. Significant differences were found in FAZ size between different DR stages. Over 80% of patients with DR showed microaneurysms, while non-perfusion areas and IRMA were more prevalent in advanced stages. The duration of diabetes was strongly associated with the extent of FAZ enlargement and severity of retinal changes.


Conclusion: OCTA provides a high-resolution, non-invasive, and reproducible method for detecting microvascular changes in diabetic patients before clinical symptoms manifest. FAZ area and retinal microvascular abnormalities can be used as sensitive biomarkers for DR staging and prognosis. Integrating OCTA into routine diabetic screening can significantly reduce vision loss through early detection and timely intervention.


 

Abstract 0 | PDF Downloads 0

References

1. International Diabetes Federation. IDF Diabetes Atlas, 10th ed. 2021.
2. Yau JWY, et al. Global prevalence and risk factors of diabetic retinopathy. Diabetes Care. 2012.
3. Basit A, et al. Diabetic Retinopathy in Pakistan: Prevalence and associated risk factors. JPMA, 2018.
4. Early Treatment Diabetic Retinopathy Study (ETDRS). Arch Ophthalmol. 1991.
5. Klein R, et al. Epidemiology of retinal vein occlusion. Ophthalmology. 2007.
6. Ding J, Wong TY. Current epidemiology of diabetic retinopathy. J Clin Endocrinol Metab. 2012.
7. Spaide RF, et al. Optical Coherence Tomography Angiography. Retina. 2015.
8. Jia Y, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012.
9. de Carlo TE, et al. Retinal Microvasculature in Diabetes. Ophthalmology Retina. 2016.
10. Hwang TS, et al. Optical coherence tomography angiography features of diabetic retinopathy. JAMA Ophthalmol. 2015.
11. Samara WA, et al. Correlation of FAZ and visual acuity in healthy and DR eyes. IOVS. 2015.
12. Salz DA, et al. FAZ in diabetic eyes using OCTA. Retina. 2016.
13. Sim DA, et al. Macular ischemia in DR. Br J Ophthalmol. 2014.
14. Freiberg FJ, et al. OCT angiography of the FAZ. Graefe's Arch Clin Exp Ophthalmol. 2016.
15. Ishibazawa A, et al. Characteristics of diabetic retinopathy using OCT angiography. Ophthalmic Res. 2016.
16. Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TT, de Clerck E, Polivka Jr J, Potuznik P, Polivka J, Stetkarova I. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation. Epma Journal. 2023 Mar;14(1):21-42.
17. Muhammad Junaid MJ, Fawad Ahmed FA, Ziaur Rehman ZR, Irfan Ali IA, Tayyaba Arshad TA. The Impact of Type 2 Diabetes Mellitus Duration on Diminishing Visual Acuity in Pakistan. InMedical Forum Monthly 2024 Nov 30 (Vol. 35, No. 11).
18. Shugufta Shakeel M, Malik MS, Rani S, Shah S. Evaluation of Variation in Platelet Indices among Patients with Diabetes Mellitus Attending Tertiary Care Hospital. Evaluation. 2023 Apr;11(4).
19. Balooch Hasankhani M, Mirzaei H, Karamoozian A. Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019. Scientific Reports. 2023 Dec 11;13(1):21908.
20. Chaudhary S, Zaveri J, Becker N. Proliferative diabetic retinopathy (PDR). Disease-a-Month. 2021 May 1;67(5):101140.
21. Salvetat ML, Pellegrini F, Spadea L, Salati C, Musa M, Gagliano C, Zeppieri M. The treatment of diabetic retinal edema with intravitreal steroids: how and when. Journal of Clinical Medicine. 2024 Feb 26;13(5):1327.
22. Häner NU, Dysli C, Munk MR. Imaging in retinal vascular disease: A review. Clinical & Experimental Ophthalmology. 2023 Apr;51(3):217-28.
23. Moir J, Khanna S, Skondra D. Review of OCT angiography findings in diabetic retinopathy: insights and perspectives. International Journal of Translational Medicine. 2021 Nov 16;1(3):286-305.
24. Sampson DM, Dubis AM, Chen FK, Zawadzki RJ, Sampson DD. Towards standardizing retinal optical coherence tomography angiography: a review. Light: science & applications. 2022 Mar 18;11(1):63.
25. Koutsiaris AG, Batis V, Liakopoulou G, Tachmitzi SV, Detorakis ET, Tsironi EE. Optical coherence tomography angiography (OCTA) of the eye: a review on basic principles, advantages, disadvantages and device specifications. Clinical hemorheology and microcirculation. 2023 Apr 7;83(3):247-71.
26. Mumtaz, Seema N et al. "Prevalence of diabetic retinopathy in Pakistan; A systematic review." Pakistan journal of medical sciences vol. 34,2 (2018): 493-500. doi:10.12669/pjms.342.13819